New hope for Tough-to-Treat colon cancer
NCT ID NCT07391566
Summary
This study is testing a new oral drug, LPM6690176, to see if it is safe and effective when added to standard chemotherapy for people with advanced colorectal cancer that has spread and has a specific genetic change (RAS mutation). The first part of the study will find the safest dose, and the second part will compare the new combination to standard treatment to see if it works better. It is for adults who have either not yet received treatment for their advanced cancer or whose first treatment stopped working.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER (MCRC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Cancer Hospital
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.